Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Cho Pharma Inc. (6586)
Market Open
15 Oct, 05:30 AM
TWSE
All
(8)
DE
(5)
TW
(1)
JP
(1)
US
(1)
JPX
Primary
TWSE
XHAN
XSTU
XDUS
XFRA
OTC GREY
XMUN
NT$
106.
00
-1.5
-1.3953%
NT$
-
Market Cap
37.69
P/E Ratio
80%
Div Yield
284,733
Volume
0
Eps
NT$
107.5
Previous Close
Watching
Watch
Add Transaction
Day Range
104.5
108.5
Year Range
22.75
148.5
Want to track
6586
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Cho Pharma Inc. (6586) Statistics
Valuation metrics
Market Cap
-
Enterprise value
24.67B
Trailing P/E (ttm)
-92.4
Forward P/E
-
PEG ratio
4.46
Price/Sales (ttm)
14,497.49
Price/Book (mrq)
10.42
Enterprise Value/Revenue
14,466.45
Enterprise Value/EBITDA
-88.76
Overview
Shares outstanding
-
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
671.32K
Average volume (90 days)
689.31K
Price summary
52-Week low
22.75
52-Week high
148.5
Beta
-
50-Day moving average
108.12
200-Day moving average
87.89
Dividends and splits
Forward annual dividend rate
-
Forward annual dividend yield
-
Trailing annual dividend rate
-
Trailing annual dividend yield
-
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
29 Sep 2026
Ex-Dividend Date
29 Sep 2026
Last split factor
2:1
Last split Date
29 Mar 2017
Financials
Fiscal year
Fiscal year ends
-
Most recent quarter (mrq)
-
Profitability
Profit margin
-157.21%
Operating margin
-176.94%
Operational effectiveness
Return on assets
-0.11%
Return on equity
-0.11%
Income Statement
Revenue (ttm)
-
Revenue per share (ttm)
0.01
Quarterly revenue growth (yoy)
-
Gross profit (ttm)
-
EBITDA
-
Net income to common (ttm)
-
Diluted EPS (ttm)
-1.25
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
-
Total cash per share (mrq)
9.16
Total debt (mrq)
-
Total Debt/Equity (mrq)
0
Current ratio (mrq)
21.96%
Book value per share (mrq)
11.09
Cash Flow
Cash flow statement
-
Levered free cash flow (LFCF)
-